Skip to main content

Therapeutic Application of Mesenchymal Stromal Cells in Murine Models of Inflammatory Bowel Disease

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1213))

Abstract

Mesenchymal stromal cells (MSCs) are currently under investigation for the treatment of inflammatory bowel disease (IBD), including Crohn’s disease. The models of colitis induced by intrarectal infusion of 2,4,6-trinitrobenzene sulfonic acid (TNBS) or by oral administration of dextran sulfate sodium (DSS) in susceptible mouse strains have been commonly used as preclinical tools to demonstrate the efficiency of treatments with MSCs isolated from various sources. Both models are being and will be critical to improve MSC-based therapies in human IBD by assaying new pathways, therapeutic regimes and tissue targeting strategies. Here, we describe our experiences in the treatment of acute and chronic TNBS- and DSS-induced colitis with MSCs.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205

    Article  CAS  PubMed  Google Scholar 

  2. Strober W, Fuss IJ, Blumberg RS (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20:495–549

    Article  CAS  PubMed  Google Scholar 

  3. Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521–533

    Article  CAS  PubMed  Google Scholar 

  4. Ucelli A, Moreta L, Pistoia V (2008) Mesenchymal stem cells in Elath and disease. Nat Rev Immunol 8:726–736

    Article  Google Scholar 

  5. Gonzalez-Rey E, Anderson P, Gonzalez MA et al (2009) Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58:929–939

    Article  CAS  PubMed  Google Scholar 

  6. Gonzalez MA, Gonzalez-Rey E, Rico L et al (2009) Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136:978–989

    Article  PubMed  Google Scholar 

  7. Zhang Q, Shi S, Liu Y et al (2009) Mesenchymal stem cells derived from human gingival are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 183: 7787–7798

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Castelo-Branco MT, Soares ID, Lopes DV et al (2012) Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. PLoS One 7: e33360

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Kim HS, Shin TH, Lee BC et al (2013) Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2. Gastroenterology 145: 1392–1403

    Article  CAS  PubMed  Google Scholar 

  10. Zani A, Cananzi M, Fascetti-Leon F et al (2014) Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. Gut 63:300–309

    CAS  PubMed  Google Scholar 

  11. Anderson P, Souza-Moreira L, Morell M et al (2013) Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut 62:1131–1141

    Article  CAS  PubMed  Google Scholar 

  12. Parolini O, Souza-Moreira L, O’Valle F et al (2014) Therapeutic effect of human amniotic membrane-derived cells in experimental arthritis and other inflammatory disorders. Arthritis Rheumatol. 66:327–339

    Article  CAS  PubMed  Google Scholar 

  13. Duijvestein M, Vos AC, Roelofs H et al (2010) Autologous bone marrow derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study. Gut 59:1662–1669

    Article  PubMed  Google Scholar 

  14. Duijvestein M, Wildenberg ME, Welling MM et al (2011) Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells 29:1549–1558

    Article  CAS  PubMed  Google Scholar 

  15. Ko IK, Kim BG, Awadallah A et al (2010) Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther 18:1365–1372

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mario Delgado .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this protocol

Cite this protocol

Gonzalez-Rey, E., Delgado, M. (2014). Therapeutic Application of Mesenchymal Stromal Cells in Murine Models of Inflammatory Bowel Disease. In: Christ, B., Oerlecke, J., Stock, P. (eds) Animal Models for Stem Cell Therapy. Methods in Molecular Biology, vol 1213. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1453-1_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1453-1_27

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1452-4

  • Online ISBN: 978-1-4939-1453-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics